BR100 Increased By (0.73%)
BR30 Increased By (0.59%)
KSE100 Increased By (0.73%)
KSE30 Increased By (0.76%)
AGHA 7.80 Increased By ▲ 0.05 (0.65%)
BECO 5.21 Increased By ▲ 0.02 (0.39%)
BML 57.01 Decreased By ▼ -1.65 (-2.81%)
BOP 34.21 Increased By ▲ 0.52 (1.54%)
CNERGY 10.80 Increased By ▲ 0.19 (1.79%)
CSIL 5.42 Increased By ▲ 0.12 (2.26%)
FCCL 54.85 Increased By ▲ 1.11 (2.07%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.44 Increased By ▲ 0.16 (2.2%)
KOSM 5.78 Increased By ▲ 0.14 (2.48%)
LOTCHEM 29.78 Increased By ▲ 0.13 (0.44%)
MLCF 95.70 Decreased By ▼ -0.66 (-0.68%)
NBP 204.50 Increased By ▲ 0.97 (0.48%)
NCPL 57.81 Increased By ▲ 0.96 (1.69%)
NPL 69.27 Increased By ▲ 1.96 (2.91%)
OGDC 318.50 Increased By ▲ 0.28 (0.09%)
PACE 10.85 Increased By ▲ 0.22 (2.07%)
PAEL 43.00 Increased By ▲ 1.23 (2.94%)
PIBTL 16.88 Increased By ▲ 0.07 (0.42%)
PPL 221.25 Increased By ▲ 1.08 (0.49%)
PRL 51.40 Increased By ▲ 2.35 (4.79%)
PTC 71.15 Increased By ▲ 1.14 (1.63%)
SSGC 28.77 Decreased By ▼ -0.37 (-1.27%)
TBL 9.94 Increased By ▲ 0.17 (1.74%)
TELE 8.90 Increased By ▲ 0.08 (0.91%)
TPL 18.30 Increased By ▲ 1.13 (6.58%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 22.72 Increased By ▲ 0.13 (0.58%)
TRG 59.95 Decreased By ▼ -0.27 (-0.45%)
World

Italy's Draghi dismisses China's COVID vaccine, casts doubt on Sputnik

  • "The Russian vaccine Sputnik has never been able to get approval from EMA and perhaps it never will," Draghi said.
Published Updated
By

BRUSSELS: Italian Prime Minister Mario Draghi said China's anti-COVID vaccine did not fully work and questioned whether Russia's Sputnik jab would ever get approval from European regulators.

"The Chinese vaccine ... has shown itself not to be adequate. You can see that from Chile's experience of tackling the epidemic," Draghi told reporters at the end of a European Union summit.

Chile has relied heavily on the COVID-19 shot developed by China's Sinovac, but health authorities in the South American country have questioned how effective it is against more transmissible virus variants and are also looking into how long it remains effective once injected.

A study published in April said the Chinese vaccine proved minimally effective at preventing illness after one dose. With a second jab, it was 67% effective in preventing symptomatic infection, 85% effective in preventing hospitalizations and 80% in preventing deaths.

Draghi also questioned Russia's Sputnik vaccine.

The European Medicines Agency (EMA) had been expected to conclude its review of the Russian jab and issue a decision in May or June. However, approval was delayed because the makers missed a June 10 deadline to submit data, sources told Reuters earlier this month.

"The Russian vaccine Sputnik has never been able to get approval from EMA and perhaps it never will," Draghi said.

Comments

Comments are closed for this article.